Skip to main content
SpringerLink
Log in

The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

Controversy still exists in the relationship between p53 codon72 polymorphism and the risk of endometrial cancer.

Materials and methods

In order to figure out this inconsistency, database on HuGE Navigator, PubMed and Web of Science about the case–control studies were compiled in the present work. Statistic analysis was performed by STATA 12.0.

Results

Total 11 eligible publications were selected in this meta-analysis including 1086 endometrial cancer and 1403 controls. There was no significant relationship between codon72 polymorphism of p53 gene and the risk of endometrial cancer under allele model [Pro versus Arg: OR 0.99, 95 % CI (0.87, 1.15)], dominant model [ArgPro + ProPro versus ArgArg: OR 0.88, 95 % CI (0.67, 1.15)], recessive model [ProPro versus ArgArg + ArgPro: OR 1.09, 95 % CI (0.84, 1.42)] and addictive model [ProPro versus ArgArg: OR 0.97, 95 % CI (0.72, 1.29)]. Samples from endometrial tissue with homozygous ArgArg have the increased risk of EC [allele model: OR 0.71, 95 % CI (0.53, 0.96); addictive model: OR 0.46, 95 % CI (0.24, 0.87)].

Conclusion

This meta-analysis revealed a weak association between the codon72 polymorphism of p53 gene and the risk of endometrial cancer. Women with homozygous Arg72 may be more susceptible to endometrial cancer than others with heterozygotes and homozygous Pro72.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Sorosky JI (2008) Endometrial cancer. Obstet Gynecol 111(2 Pt 1):436–447. doi:10.1097/AOG.0b013e318162f690

    Article  PubMed  Google Scholar 

  2. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. Ca Cancer J Clin 63(1):11–30

    Article  PubMed  Google Scholar 

  3. Cancer Research UK. Uterine cancer incidence statistics. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/uterus/incidence/. Accessed 26 Apr 2015

  4. Galaal K, Al Moundhri M, Bryant A, Lopes AD, Lawrie TA (2014) Adjuvant chemotherapy for advanced endometrial cancer. Cochrane Database Syst Rev 5:CD010681. doi:10.1002/14651858.CD010681.pub2

    PubMed  Google Scholar 

  5. Murali R, Soslow RA, Weigelt B (2014) Classification of endometrial carcinoma: more than two types. Lancet Oncol 15(7):e268–e278. doi:10.1016/s1470-2045(13)70591-6

    Article  PubMed  Google Scholar 

  6. Fornasarig M, Campagnutta E, Talamini R, Franceschi S, Boz G, Scarabelli C, Andreaus CM, Scozzari G, Valentini M (1998) Risk factors for endometrial cancer according to familial susceptibility. Int J Cancer 77(1):29–32

    Article  CAS  PubMed  Google Scholar 

  7. Lorenzo Bermejo J, Buchner FL, Hemminki K (2004) Familial risk of endometrial cancer after exclusion of families that fulfilled Amsterdam, Japanese or Bethesda criteria for HNPCC. Ann Oncol 15(4):598–604

    Article  CAS  PubMed  Google Scholar 

  8. Win AK, Reece JC, Ryan S (2015) Family history and risk of endometrial cancer: a systematic review and meta-analysis. Obstet Gynecol 125(1):89–98. doi:10.1097/AOG.0000000000000563

    Article  PubMed  Google Scholar 

  9. Britschgi C, Fey MF (2009) Tumor suppressor genes in myeloid differentiation and leukemogenesis. Future Oncol 5(2):245–257. doi:10.2217/14796694.5.2.245

    Article  CAS  PubMed  Google Scholar 

  10. Koshiyama M, Ueta M (2002) Two kinds of endometrial neoplasia arising from different origins in the uterine corpus: comparison of p53 expression and sex steroid receptor status. Eur J Obstet Gyn R B 104(2):167–170

    Article  CAS  Google Scholar 

  11. Zajac A, Smolarz B, Stachowiak G, Wilczynski JR (2014) TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women. Med Oncol 31(11):286. doi:10.1007/s12032-014-0286-z

    Article  PubMed  PubMed Central  Google Scholar 

  12. Levine AJ, Oren M (2009) The first 30 years of p53: growing ever more complex. Nat Rev Cancer 9(10):749–758. doi:10.1038/nrc2723

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Garcia PB, Attardi LD (2014) Illuminating p53 function in cancer with genetically engineered mouse models. Semin Cell Dev Biol 27:74–85

    Article  CAS  PubMed  Google Scholar 

  14. Zajac A, Stachowiak G, Smolarz B, Wilczynski JR (2013) Polymorphisms of codon 72 of the TP53 gene in endometrial carcinoma of postmenopausal women. Postepy Hig Med Dosw (Online) 67:1312–1318

    Article  Google Scholar 

  15. Kataoka M, Okabayashi T, Johira H, Nakatani S, Nakashima A, Takeda A, Nishizaki M, Orita K, Tanaka N (2000) Aberration of p53 and DCC in gastric and colorectal cancer. Oncol Rep 7(1):99–103

    CAS  PubMed  Google Scholar 

  16. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. doi:10.1002/sim.1186

    Article  PubMed  Google Scholar 

  17. Zubor P, Hatok J, Moricova P, Kajo K, Kapustova I, Mendelova A, Racay P, Danko J (2015) Gene expression abnormalities in histologically normal breast epithelium from patients with luminal type of breast cancer. Mol Biol Rep 42(5):977–988

    Article  CAS  PubMed  Google Scholar 

  18. Brachova P, Mueting SR, Carlson MJ, Goodheart MJ, Button AM, Mott SL, Dai DH, Thiel KW, Devor EJ, Leslie KK (2015) TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma. Int J Oncol 46(2):607–618

    CAS  PubMed  Google Scholar 

  19. Bellini MF, Cadamuro ACT, Succi M, Proenca MA, Silva AE (2012) Alterations of the TP53 gene in gastric and esophageal carcinogenesis. J Biomed Biotechnol 2012:891961

    Article  PubMed  PubMed Central  Google Scholar 

  20. Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A, Del Sal G, Syed N, Smith P, Gasco M, Crook T, Lu X (2006) iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72 polymorphic p53. Nat Genet 38(10):1133–1141

    Article  CAS  PubMed  Google Scholar 

  21. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19(2):1092–1100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Dumont P, Leu JIJ, Della Pietra AC, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33(3):357–365

    Article  CAS  PubMed  Google Scholar 

  23. Pim D, Banks L (2004) p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108(2):196–199

    Article  CAS  PubMed  Google Scholar 

  24. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393(6682):229–234. doi:10.1038/30400

    Article  CAS  PubMed  Google Scholar 

  25. Malisic E, Jankovic R, Brotto K, Radulovic S (2013) TP53 codon 72 polymorphism and risk of cervical carcinoma in Serbian women. Arch Gynecol Obstet 288(3):621–625. doi:10.1007/s00404-013-2783-2

    Article  CAS  PubMed  Google Scholar 

  26. Kafshdooz T, Tabrizi AD, Ardabili SMM, Kafshdooz L, Ghojazadeh M, Gharesouran J, Abdii A, Alizadeh H (2014) Polymorphism of p53 Gene Codon 72 in endometrial cancer: correlation with tumor grade and histological type. Asian Pac J Cancer Prev 15(22):9603–9606. doi:10.7314/apjcp.2014.15.22.9603

    Article  PubMed  Google Scholar 

  27. Roh JW, Kim JW, Park NH, Song YS, Park IA, Park SY, Kang SB, Lee HP (2004) p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer. Gynecol Oncol 93(2):499–505. doi:10.1016/j.ygyno.2004.02.005

    Article  CAS  PubMed  Google Scholar 

  28. Gu Y, Zhou X, Zhang SL (2011) Meta-analysis of an association of codon 72 polymorphisms of the p53 gene with increased endometrial cancer risk. Genet Mol Res 10(4):3609–3619. doi:10.4238/2011.October.31.11

    Article  CAS  PubMed  Google Scholar 

  29. Khan MH, Khalil A, Rashid H (2015) Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: a HuGE review and meta-analysis. Genet Res (Camb) 97:e7. doi:10.1017/S0016672315000075

    Article  Google Scholar 

  30. Mitchell AA, Cutler DJ, Chakravarti A (2003) Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test. Am J Hum Genet 72(3):598–610. doi:10.1086/368203

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Jongen VHWM, Briet JM, de Jong RA, Joppe E, ten Hoor KA, Boezen HM, Evans DB, Hollema H, van der Zee AGJ, Nijman HW (2009) Aromatase, cyclooxygenase 2, HER-2/neu, and P53 as prognostic factors in endometrioid endometrial cancer. Int J Gynecol Cancer 19(4):670–676

    Article  PubMed  Google Scholar 

  32. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U, Scott RJ (2009) Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer. Gynecol Oncol 113(1):109–114. doi:10.1016/j.ygyno.2008.12.036

    Article  CAS  PubMed  Google Scholar 

  33. Janiec-Jankowska A, Konopka B, Goluda C, Najmola U (2010) TP53 mutations in endometrial cancers: relation to PTEN gene defects. Int J Gynecol Cancer 20(2):196–202

    Article  PubMed  Google Scholar 

  34. Garcia-Dios DA, Lambrechts D, Coenegrachts L, Vandenput I, Capoen A, Webb PM, Ferguson K, Akslen LA, Claes B, Vergote I, Moerman P, Van Robays J, Marcickiewicz J, Salvesen HB, Spurdle AB, Amant F (2013) High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma. Gynecol Oncol 128(2):327–334. doi:10.1016/j.ygyno.2012.11.037

    Article  CAS  PubMed  Google Scholar 

  35. Esteller M, GarcÃa A, MartÃnez-Palone JM, Xercavin J, Reventà J (1997) Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci. Br J Cancer 75(9):1385–1388

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Peller Shoshana, Halperin Rehuvit, Schneider D (1999) Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma. Oncol Rep 6:193–197

    CAS  PubMed  Google Scholar 

  37. Agorastos T, Masouridou S, Lambropoulos AF, Chrisafi S, Miliaras D, Pantazis K, Constantinides TC, Kotsis A, Bontis I (2004) P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women. Eur J Cancer Prev 13(4):277–280

    Article  CAS  PubMed  Google Scholar 

  38. Niwa Y, Hirose K, Matsuo K, Tajima K, Ikoma Y, Nakanishi T, Nawa A, Kuzuya K, Tamakoshi A, Hamajima N (2005) Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Cancer Lett 219(2):183–190. doi:10.1016/j.canlet.2004.10.018

    Article  CAS  PubMed  Google Scholar 

  39. Ueda M, Terai Y, Kanda K, Kanemura M, Takehara M, Yamaguchi H, Nishiyama K, Yasuda M, Ueki M (2006) Germline polymorphism of p53 codon 72 in gynecological cancer. Gynecol Oncol 100(1):173–178. doi:10.1016/j.ygyno.2005.08.015

    Article  CAS  PubMed  Google Scholar 

  40. Nunobiki O, Ueda M, Yamamoto M, Toji E, Sato N, Izuma S, Okamoto Y, Torii K, Noda S (2009) Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer. Hum Cell 22(4):101–106. doi:10.1111/j.1749-0774.2009.00075.x

    Article  PubMed  Google Scholar 

  41. Zubor P, Stanclova A, Kajo K, Hatok J, Klobusiakova D, Visnovsky J, Danko J (2009) The p53 codon 72 exon 4 BstUI polymorphism and endometrial cancer in Caucasian women. Oncology 76(3):173–183. doi:10.1159/000201570

    Article  CAS  PubMed  Google Scholar 

  42. Ghasemi N, Karimi-Zarchi M, Mortazavi-Zadeh MR, Atash-Afza A (2010) Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer. Cancer Genet Cytogenet 196(2):167–170. doi:10.1016/j.cancergencyto.2009.09.013

    Article  CAS  PubMed  Google Scholar 

  43. Yoneda T, Kuboyama A, Kato K, Ohgami T, Okamoto K, Saito T, Wake N (2013) Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer. Oncol Rep 30(1):25–34. doi:10.3892/or.2013.2433

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou, 510632, Guangdong, People’s Republic of China

    Xinzi Lin, Chenlingzi Huang & Xin Luo

  2. The Department of Orthopedics, The First Affiliated Hospital of Jinan University, Guangzhou, 510632, Guangdong, People’s Republic of China

    Dabiao Hou

Authors
  1. Xinzi Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dabiao Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chenlingzi Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xin Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xinzi Lin or Xin Luo.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, X., Hou, D., Huang, C. et al. The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis. Arch Gynecol Obstet 294, 353–359 (2016). https://doi.org/10.1007/s00404-015-4005-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-015-4005-6

Keywords

Search

Navigation